DISCvision has recently conducted, together with samhealth, DISC-lifestyle studies on healthcare topics commissioned by Novartis, Astellas, Roche, Bayer, Astra Zenica, MSD, Amgen, Fresenius Kabi, Celgene, Chisi, Janssen, Piere Fabre, Sanofi, Vivor Farma, and Philips and several healthcare services. The outcomes are implemented in therapy compliance, marketing, communication and healthcare management.

The drivers and barriers of patients and medical professionals were investigated in the area of cardio vascular diseases, sclerosis, osteoporosis, prostate cancer, diabetes, myelofibrose, psoriasis, non-Hodgkin’s lymphoma, atomizing antibiotics, muscle relaxants, niercelcarcinoom, depression, HPV, macula degeneration, multiple sclerosis, vaccinations, metastatic melonoma, bechterew, carcenoom ovaries, breast cancer, blood clots, menopausal symptoms, rheumatism, lung cancer, hyperkalimie and several other diseaeses.